Ivim Health vs MangoRx: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

52 providers verified independently·Independent research·How we rank →

Ivim Health beats MangoRx overall, scoring 7.9/10 vs 7.5/10. Ivim Health is more affordable at $150/mo vs $299/mo. Choose Ivim Health for users who want personalized dosing with frequent provider ch. Choose MangoRx for needle-phobic users who want oral-only glp-1 tablets from a .

A side-by-side look at Ivim Health and MangoRx to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Higher Rated

Ivim Health

#8 of 52

7.9/10

Personalized GLP-1 program with frequent provider check-ins and customized dosing schedules at an affordable price point.

Visit Ivim Health

MangoRx

#26 of 52

7.5/10

Multi-service telehealth platform offering compounded GLP-1 alongside other health services.

Visit MangoRx

Feature	Ivim Health	MangoRx
Our Score	7.9/10	7.5/10
Starting Price	$150/mo	$299/mo
Medication Type	Both	Compounded
Insurance Accepted	No	No
Best For	Users who want personalized dosing with frequent provider check-ins	Needle-phobic users who want oral-only GLP-1 tablets from a publicly traded company
Ranking	#8	#26
Get started	Visit Ivim Health	Visit MangoRx

Pros & Cons Compared

Ivim Health

Pros

+$75/mo starting price is among the lowest in the market for a program with actual provider oversight
+Bi-weekly provider check-ins included, more frequent than most platforms at this price point
+Personalized titration schedules based on individual tolerance, not cookie-cutter dose escalation
+Both brand-name and compounded available, with the option to switch based on response

Cons

−The $75/mo starting price increases with dose, expect $150-200/mo at maintenance doses
−No insurance billing, and the cost increase at higher doses isn't always clearly communicated upfront

MangoRx

Pros

+Oral dissolving tablets exclusively, zero injections for any GLP-1 option
+Publicly traded on NASDAQ (MGRX), SEC-required financial transparency that private competitors can't match
+Semaglutide tablet includes Vitamin B6 to help reduce nausea during treatment
+Free 100% online consultation with no video call required

Cons

−Oral semaglutide at $299/mo runs 2-3x injectable alternatives ($99-149/mo). The premium only makes sense if needles are a hard no for you.
−Early-stage public company with limited revenue; the same SEC filings that provide transparency also show the financial uncertainty reflected in the stock.
−Oral tablets are the only format, with no injectable option if you want higher bioavailability. If you may switch to injections later, pick a platform that carries both.

Our Verdict

Ivim Health edges out MangoRx with a score of 7.9/10 vs 7.5/10. If budget is your priority, Ivim Health starts at $150/mo compared to MangoRx's $299/mo. Ivim Health offers both brand-name and compounded medications, giving you more flexibility. Choose Ivim Health if you want: users who want personalized dosing with frequent provider check-ins. Choose MangoRx if you want: needle-phobic users who want oral-only glp-1 tablets from a publicly traded company.

Still undecided? Editor's Featured Pick

Yucca Health

$146/mo · 7.7/10 · Compounded

If neither Ivim Health nor MangoRx feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.

Visit Yucca Health→Read our full Yucca Health review